ArticleJournal of neuroinflammation2026
OSBPL10 alleviates neuronal ferroptosis via lysosomal membrane repair in a PS-dependent manner after spinal cord injury.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ferroptosis-Pyroptosis Crosstalk in Spinal Cord Injury: Molecular Mechanisms, Emerging Connectors, and Staged Therapeutic Perspectives.Journal of molecular neuroscience : MN · 2026Review
- The ferroptosis-mediated domino effect: metabolic crosstalk from intervertebral disc degeneration to spinal deformity and cord injury: a mini review.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) exerts severe adverse effects on patients, leading to impaired motor functions in segments remote from the injury site. Following SCI, lysosomes are damaged due to inflammatory microenvironment, and the repair of such damage requires a substantial supply of lipids. Studies have demonstrated that lipid transfer proteins (LTPs) play a pivotal role in the repair process of neuronal organelles. However, whether these proteins regulate functional recovery after SCI and their underlying mechanisms remain elusive. Through RNA sequencing and human cerebrospinal fluid enzyme-linked immunosorbent assay (ELISA) analyses, we verified that OSBPL10 is significantly downregulated in the acute phase of SCI and may serve as a protective factor against SCI. The Basso Mouse Scale (BMS), Nissl staining, and two-dimensional (2D) gait analysis were employed to evaluate functional recovery. Western blotting and immunofluorescence assays were performed to detect the expression changes of proteins associated with autophagy, ferroptosis, oxidative stress, and lysosomal membrane permeabilization (LMP) related proteins. Finally, molecular docking and rescue experiments using lipid synthesis inhibitors further confirmed that OSBPL10 ameliorate LMP by transferring PS to lysosomes, thereby promoting autophagic flux. Collectively, our findings conclude that OSBPL10 overexpression alleviates autophagic flux impairment, ferroptosis, and oxidative stress after SCI through PS-mediated lysosomal repair, thus facilitating post-injury neurological function recovery and holding promising potential for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.